China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS)
CNY 20.02
(-0.2%)
CNY 20.02
(-0.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.65 Billion | 1.34 Billion | 1.34 Billion | 1.36 Billion | 1.43 Billion | 1.46 Billion |
| Net Income | 1.33 Billion | 1.21 Billion | 972.13 Million | 1.01 Billion | 1.06 Billion | 989.45 Million |
| Depreciation & Amortization | 655.45 Million | 540.58 Million | 464.99 Million | 371.7 Million | 357.4 Million | 343.71 Million |
| Deferred income taxes | -18.1 Million | -20.72 Million | -23.77 Million | -3.08 Million | -3.19 Million | -13.76 Million |
| Stock-based compensation | 50.03 Million | 2.1 Million | - | - | - | - |
| Change in working capital | -412.59 Million | -413.48 Million | -143.45 Million | -62.37 Million | -31.32 Million | 152.63 Million |
| Other non-cash items | 1.79 Billion | -16.07 Million | 47.24 Million | 37.32 Million | 47.26 Million | -16.76 Million |
| Investing Cash Flow | -707.76 Million | 666.78 Million | -569.8 Million | -417.98 Million | -1.06 Billion | -823.48 Million |
| Investments in PPE | -604.46 Million | -525.53 Million | -491.67 Million | -348.08 Million | -241.64 Million | -228.68 Million |
| Acquisitions | -127.22 Million | -409.22 Million | 36.59 Million | 42.65 Million | -112.79 Million | -257.72 Million |
| Investment purchases | -2.34 Billion | -1.35 Billion | -3.19 Billion | -2.42 Billion | -3.06 Billion | -2.01 Billion |
| Sales/Maturities of investments | 2.3 Billion | 2.95 Billion | 3.05 Billion | 2.29 Billion | 2.34 Billion | 1.67 Billion |
| Other Investing Activities | 60.94 Million | -189.17 Thousand | 33.42 Million | 12.86 Million | 6.52 Million | 3.97 Million |
| Financing Cash Flow | -358.32 Million | -1.29 Billion | -378.61 Million | -386.17 Million | -524.85 Million | -803.14 Million |
| Debt repayment | -9.32 Million | -6.19 Million | -47.69 Million | -64.3 Million | -306.9 Million | -36.65 Million |
| Dividends payments | -300.48 Million | -799.18 Million | -302.53 Million | -317.14 Million | -291.06 Million | -91.11 Million |
| Common Stock Repurchased | -1.01 Million | -290.9 Million | - | - | - | - |
| Common Stock Issuance | -29.71 Million | 144.72 Million | - | - | - | - |
| Other Financing Activities | -17.77 Million | -337.04 Million | -28.33 Million | -2.54 Million | 81.2 Million | -675.37 Million |
| Accounts receivables | -488.66 Million | -266.24 Million | -130.71 Million | -216.16 Million | -369.83 Million | -254.96 Million |
| Accounts payables | -221.59 Million | -92.22 Million | 395.5 Million | 303.63 Million | 526.81 Million | 426.27 Million |
| Inventory | 315.67 Million | -34.3 Million | -384.46 Million | -146.76 Million | -185.11 Million | -4.9 Million |
| Other working capital | -18 Million | -20.72 Million | -23.77 Million | -3.08 Million | -3.19 Million | 157.53 Million |
| Cash at beginning of period | 2.63 Billion | 1.88 Billion | 1.49 Billion | 935.39 Million | 1.08 Billion | 1.24 Billion |
| Cash at end of period | 3.21 Billion | 2.61 Billion | 1.88 Billion | 1.49 Billion | 935.39 Million | 1.08 Billion |
| Capital Expenditure | -604.46 Million | -525.53 Million | -491.67 Million | -348.08 Million | -241.64 Million | -228.68 Million |
| Effect of forex changes on cash | 3.69 Million | 12.27 Million | 1.3 Million | -68.59 Thousand | -26.36 Thousand | 43.57 Thousand |
| Net cash flow / Change in cash | 585.83 Million | 729.55 Million | 393.79 Million | 555.92 Million | -154.39 Million | -157.54 Million |
| Free Cash Flow | 1.04 Billion | 816.13 Million | 849.24 Million | 1.01 Billion | 1.19 Billion | 1.24 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 350.53 Million | 630.42 Million | 416.1 Million | 255.25 Million | 1.33 Billion | 300.97 Million |
| Depreciation & Amortization | - | 184.75 Million | 184.75 Million | 640.8 Million | 655.45 Million | -300 Million |
| Deferred income taxes | - | - | - | 199.05 Thousand | -18.1 Million | - |
| Stock-based compensation | - | - | - | 50.03 Million | 50.03 Million | - |
| Change in working capital | - | -510.6 Million | - | -172.16 Million | -412.59 Million | 331.4 Million |
| Other non-cash items | 177.38 Million | 213.94 Million | -112.95 Million | -173.42 Million | 1.79 Billion | 45.92 Million |
| Investing Cash Flow | -304.08 Million | 1.32 Billion | 43.49 Million | 4.44 Million | -707.76 Million | 273.31 Million |
| Investments in PPE | -307.41 Million | -115.95 Million | -98.53 Million | -241.7 Million | -604.46 Million | -141.07 Million |
| Acquisitions | 3.09 Million | 51.1 Million | 1.73 Million | -130.17 Million | -127.22 Million | 646.33 Thousand |
| Investment purchases | - | - | -100 Million | -290 Million | -2.34 Billion | -650 Million |
| Sales/Maturities of investments | - | 100.39 Million | 240.3 Million | 603.34 Million | 2.3 Billion | 1.06 Billion |
| Other Investing Activities | 3.32 Million | 1.29 Billion | 143.49 Million | 62.97 Million | 60.94 Million | 1.56 |
| Financing Cash Flow | 209.93 Million | -3.26 Billion | -12.28 Million | -199.45 Million | -358.32 Million | -130.87 Million |
| Debt repayment | -488.64 Million | -68.85 Million | -2.26 Million | -1.88 Million | -9.32 Million | -1.38 Million |
| Dividends payments | -268.29 Million | -1 Billion | -1.67 Million | -182.13 Million | -300.48 Million | -121.02 Million |
| Common Stock Repurchased | 2.28 Million | -2.28 Million | - | -1.01 Million | -1.01 Million | 292.87 Thousand |
| Common Stock Issuance | - | - | - | - | -29.71 Million | -292.87 Thousand |
| Other Financing Activities | -10.41 Million | -3.17 Billion | -10.01 Million | -15.44 Million | -17.77 Million | -8.47 Million |
| Accounts receivables | - | -624.63 Million | - | -488.66 Million | -488.66 Million | 336.05 Million |
| Accounts payables | - | - | - | - | -221.59 Million | 2.09 Million |
| Inventory | - | 113.82 Million | - | 315.67 Million | 315.67 Million | -4.65 Million |
| Other working capital | - | 196.06 Thousand | - | 825.97 Thousand | -18 Million | -2.09 Million |
| Cash at beginning of period | 2.26 Billion | 3.64 Billion | 2.96 Billion | 2.79 Billion | 2.63 Billion | 2.27 Billion |
| Cash at end of period | 2.69 Billion | 2.27 Billion | 3.64 Billion | 3.2 Billion | 3.21 Billion | 2.79 Billion |
| Capital Expenditure | -307.41 Million | -115.95 Million | -98.53 Million | -241.7 Million | -604.46 Million | -141.07 Million |
| Effect of forex changes on cash | -1.29 Million | 2.34 Million | 867.54 Thousand | -878.8 Thousand | 3.69 Million | 812.64 Thousand |
| Net cash flow / Change in cash | 432.47 Million | -1.37 Billion | 686.77 Million | 404.81 Million | 585.83 Million | 521.54 Million |
| Free Cash Flow | 220.49 Million | 543.66 Million | 204.61 Million | 359 Million | 1.04 Billion | 237.21 Million |
NEXN
600114
POLY
300507
NPK
000970